Trying ViBandz for children with neurologic movement problems
ViBandz Feasibility Study in the Neurological Pediatric Population
Children's Mercy Hospital Kansas City · NCT07458568
We will try the ViBandz vibration device with children aged 6 months to 17 years who have neurologic movement problems during their regular PT/OT clinic visit.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 6 Months to 17 Years |
| Sex | All |
| Sponsor | Children's Mercy Hospital Kansas City (other) |
| Locations | 1 site (Kansas City, Missouri) |
| Trial ID | NCT07458568 on ClinicalTrials.gov |
What this trial studies
This single-site feasibility project will test the ViBandz wearable vibration device with children who receive targeted focal vibration as part of their routine physical or occupational therapy at a Midwest pediatric tertiary care hospital. The design uses a mixed-methods approach with quantitative parent surveys completed immediately in clinic (or by email afterward) and secondary qualitative review of audio and optional video recorded during device use. All participants will receive their standard clinical targeted vibration first and then complete use of the ViBandz after their visit. The collected data will focus on feasibility, usability, and contextual feedback to guide future larger trials.
Who should consider this trial
Good fit: Children aged 6 months to 17 years with neurologic conditions causing abnormal movement of at least one extremity who have a scheduled PT/OT clinic visit including targeted focal vibration and whose parent or LAR speaks English are ideal candidates.
Not a fit: Children who are wards of the state, whose parent or LAR is not English-speaking, or who are not scheduled for targeted focal vibration in the CM PT/OT clinic are excluded and therefore unlikely to benefit.
Why it matters
Potential benefit: If successful, ViBandz could provide a simple adjunct vibration tool to support targeted therapy for improving extremity movement in children with neurologic conditions.
How similar studies have performed: Targeted focal vibration has shown promising results in small pediatric and adult studies, but ViBandz as a specific device is novel and has limited prior clinical data.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria (Children): * Children of ages 6 months to 17 years old * Neurologic conditions resulting in abnormal movement of at least one extremity * Appointment scheduled in CM PT/OT clinic that would include targeted focal vibration as a standard of care Exclusion Criteria (Children): * Wards of the state Inclusion Criteria (Parent/LAR): * Parent or Legally Authorized Representative of a child with inclusion criteria above * English-speaking Exclusion Criteria (Parent/LAR): * Non-English speaking
Where this trial is running
Kansas City, Missouri
- Children's Mercy Hospital — Kansas City, Missouri, United States (RECRUITING)
Study contacts
- Study coordinator: Megan Blaufuss, OTR/L, MS, CPAM
- Email: mmblaufuss@cmh.edu
- Phone: 913-696-5028
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pediatrics, Neurologic Dysfunction, Vibration Therapy, pediatrics, vibration therapy